Registration now open!
To register please enter ESR Connect.
ESR members EUR 49
Non-members EUR 99
Registration fees do not include VAT. VAT will be added during the registration process and will be calculated based on your country or disclosure of the VAT number of your company.
Registration fees include on-demand access until October 3, 2021.
(If you need to renew or apply for the ESR membership for 2021, please click here)
Eun-Kyung Kim, Seoul/KR
Vivian Youngjean Park, Seoul/KR
Bo-Kyung Seo, Seoul/KR
UPDATES ON BREAST CANCER SCREENING CLINICAL TRIALS ONLINE |
July 3, 2021
This course is aimed at senior residents, board-certified radiologists and fellows interested in high-quality breast imaging. The programme is articulated on imaging strategies for the breast pathologies, with emphasis on screening, and applications of AI in mammographic screening will be discussed as well. Lectures about state-of-the art mammography, breast ultrasound and breast MRI, with emphasis on screening will be presented. Renowned European and Korean lecturers will ensure a high-quality teaching programme, combining lectures and interactive cases.
- to convey in-depth knowledge on the role of mammography, ultrasound and MRI in diagnosis of breast diseases, with emphasis on the screening and high-risk screening
- to present a comprehensive and practical overview of updated current imaging protocols and derived information in the detection and evaluation of breast pathologies with emphasis on screening
- to discuss state-of-the-art imaging approaches in diagnosis and screening of breast cancer
- to present the role of AI in mammographic screening
Saturday, July 3, 2021
|Breast ultrasound 2021
Boris Brkljačić, Zagreb/HR
|Breast cancer screening guideline and current practice in Korea
Jin Chung, Seoul/KR
|AI-based CAD application in mammography screening
Jung Hyun Yoon, Seoul/KR
|Update on breast cancer screening trials
Eva Fallenberg, Munich/DE
|Multimodality screening in women with personal history of breast cancer
Su Min Ha, Seoul/KR
|MR screening in women at higher risk than average
Isabelle Thomassin-Naggara, Paris/FR
* Time in Seoul/Korea
** Time in Europe (CEST)